News

PHI and world-leading research institute evaluate quantitative imaging of living tumor cells

QIMR Berghofer Medical Research Institute in Brisbane and PHI have entered an evaluation agreement to explore the use of live cell time-lapse cytometry based on quantitative phase microscopy to determine the …
Read More

Phase Holographic Imaging launches new website

Today Phase Holographic Imaging (PHI) launches a new website. The new website has been created to comprehensively provide extensive product information, as well as an introduction to the range of cell …
Read More

University of California, San Francisco and Phase Holographic Imaging establish Center of Excellence

University of California, San Francisco (UCSF) and Phase Holographic Imaging (PHI) have agreed to expand their on-going collaboration and establish a regional Holographic Imaging Cytometry Center of Excellence, located at the …
Read More

Novel HoloMonitor method identifies tumor creating cancer cells

Using HoloMonitor®, researchers at Harvard Medical School and Boston Children’s Hospital have developed a novel non-invasive method for distinguishing between active and dormant cancer cells.
Read More

PHI Launches Wound Healing Assay

HoloMonitor® Wound Healing Assay: The assay meets the unmet market demand of both quantifying cell movement automatically and in great detail. Wound healing assays are one of the most used laboratory …
Read More

Leading Australian Research Institute Purchases HoloMonitor

A first HoloMonitor was recently deployed at QIMR Berghofer Medical Research Institute in Brisbane Australia. With the purchase, the institute upgrades its quantitative time-lapse cytometry capacity to also include instrumentation for …
Read More

PHI and Malmö University receives 2.3 million SEK to detect blood-borne cancer cells

GlycoImaging is a collaboration project between PHI, Malmö University and four international research institutions. By combining PHI’s HoloMonitor technology with a new type of cancer probes, more sensitive methods to detect …
Read More

Novel HoloMonitor based research to be presented at cancer research annual meeting

Using HoloMonitor® technology from PHI the scientists have been able to follow and measure important dynamics of cancer cells in ways not possible with conventional methods, which has led to the …
Read More

Japan´s foremost medical institute purchases multiple HoloMonitor instruments

Japan’s foremost medical research institute, The Institute of Medical Science at University of Tokyo, recently purchased two HoloMonitor M4. Together with RIKEN and Kyoto University, the institute spearheads Japan’s national effort …
Read More

EU grants 2.1 million euro to Phase Holographic Imaging and Malmö University with partners for joint cancer research

The European Commission has appointed Phase Holographic Imaging,Bundesanstalt für Material-forschung und Prüfung (Germany’s federal technology research institute), Malmö, Umeå, Copenhagen and Turku University to develop improved methods for clinically diagnosing cancer. …
Read More